INTRODUCTION
There has been great number of evidences demonstrating that metabolic dysfunction associated with obesity can progress to further health problems, which are of worldwide concern. Non-alcoholic fatty liver disease NAFLD is now recognized as a premorbid condition that can lead to liver disease-related morbidity 1, 2 and even cardiovascular disease 3 . NAFLD covers a spectrum of liver diseases, ranging from steatosis to non-alcoholic steatohepatitis NASH . In the most extreme cases of fatty liver disease, simple hepatic fat accumulation progresses to fibrosis and cirrhosis 4 . This hepatic fat accumulation is caused by dysregulation of lipid metabolism, including lipid synthesis, fatty acid oxidation, and lipoprotein uptake and secretion in the liver 5, 6 . In insulin resistance associated with obesity, both influx of abnormal free fatty acid originating from adipose tissue and de novo lipogenesis are enhanced in the lipid metabolism. Interest in marine organisms as a source of health-promoting agents has been rising in recent decades. Several studies have shown beneficial effects of n-3 long-chain polyunsaturated fatty acids PUFA from fish or seafood, such as docosahexaenoic acid DHA and eicosapentaenoic acid EPA , on the development of obesity and diabetes 8 11 ,
and others have shown a negative association between plasma n-3 PUFA levels and body weight and body composition related to obesity 12, 13 . In addition, fish oil or n-3
PUFA have been shown to improve lipid metabolism in numerous in vivo studies 14, 15 . Starfish, benthic echinoderms occur in the world s oceans, has n-3 PUFA. Especially, starfish are especially rich in EPA bound to phospholipids PL . The beneficial effects of n-3 PUFA have been studied in the form of DHA/EPA bound to triacylglycerol TG , whereas some studies have claimed that n-3 PUFA bound to PL from marine animals more effectively prevents carcinogenesis and metabolic disorders related to obesity than n-3 PUFA bound to TG 16, 17 . Furthermore, marine echinoderms are characterized by the presence of specific carotenoids such as astaxanthin and lutein 18 . Marine-derived carotenoids have also attracted the attention of the food industry because of the nutraceutical properties 19 21 . Many of the biological functions of carotenoids are linked to their antioxidant activities, which protect against reactive oxygen species ROS -induced oxidative stress in the human body. This activity reduces chronic inflammation, which causes insulin resistance, and results in improvement of metabolic disorders 21, 22 . Based on this evidence, it is possible that lipids from starfish could exert similar physiological effects on lipid metabolism and hence could be useful as agents against obesity and obesity-related diseases. However, to date there has been little investigation into the effect of lipids from starfish on high-fat diet-induced obesity. In the present study, we examined the effect of starfish oil SO on high-fat diet-induced obesity in C57BL/6N mice. This study focuses on the influence on lipid metabolism and suggests possible mechanisms for the preventive effect of SO on hyperlipidemia and hepatic lipid accumulation.
EXPERIMENTAL

Materials
The starfish Asterias amurensis were kindly provided by the Betsukai fishery cooperative Hokkaido, Japan . Organic solvents used for lipid extraction were purchased from Wako Pure Chemical Industries Osaka, Japan . 1,2 2,3 -Dioleoyl-3 1 -1-13 C -palmitoyl glycerol β-OO*P was obtained from Tsukishima Foods Industry Tokyo, Japan . All animal diet ingredients were purchased from Oriental Yeast Tokyo, Japan .
Sample preparation
The gonads and viscera of starfish were homogenized in 10 volumes of chloroform/methanol 2:1, v/v at 10,000 rpm for 5 min and mixed with a 0.88 w/v KCl solution. The water-soluble components were removed using liquid/ liquid extraction with chloroform/methanol/water 10:5:3, v/v/v . The crude lipid SO was obtained by evaporating the chloroform layer. The composition of the SO was 64 wt neutral lipids 51 wt TG, the other 13 wt containing monoacylglycerol and diacylglycerol and free fatty acid , 25 wt phospholipids, 6 wt glycolipids and 4 wt others, including carotenoids. The fatty acid composition wt of the SO was: palmitic acid, 10.7; stearic acid, 6.4; oleic acid, 10.6; eicosenoic acid, 23.2; EPA, 23.8; DHA, 5.5. The phospholipid component contained 44.4 wt n-3 PUFA, of which 33.3 wt was EPA and 5.3 wt was DHA.
Animal care and diet
Animal treatment was in accordance with the guidelines established by the Institutional Animal Care and Use Committee of the Tokyo University of Marine Science and Technology. Male C57BL/6N mice 4-wk-old; Japan SLC, Shizuoka, Japan were used. Animals were housed in plastic cages with free access to tap water and a basal rodent chow MF Oriental Yeast, Tokyo, Japan , under controlled conditions of a 12:12-hr light-dark cycle at 22 1 and 50 humidity. After a 7-day acclimation period, the animals were divided into three groups and were fed the following experimental diet based on the AIN-76 formulation: high-fat HF diet 46 fat by energy group, HF diet 2 SO group 2 SO and HF diet 5 SO group 5 SO . The ingredients and fatty acid composition of the experimental diet are summarized in Table 1 and Table 2 , respectively. Following feeding for eight weeks, blood samples were taken from the caudal vena cava of the mice under anesthesia with isoflurane Wako Pure Chemical Industries, Osaka, Japan . The liver and epididymal white adipose tissue WAT were weighed, immediately frozen, and stored at 40 until analysis.
Biochemical analysis
Blood glucose levels were measured without fasting at 3 days before dissection by using a droplet of blood collected from the tail vein, with a Glutest Neo alpha blood glucose monitor Sanwa Kagaku Kenkyusyo Co. Ltd., Aichi, Japan . This monitor determines the glucose level using FAD-dependent glucose dehydrogenase and Fe CN 6 3 .
TG, total cholesterol total-C , and HDL cholesterol HDL-C in the serum were measured using a commercial enzymatic assay kit Wako Pure Chemicals, Osaka, Japan according to the manufacturer s instructions.
Total lipid from liver was extracted using chloroform/ methanol 2:1, v/v according to the method of Folch and others 23 . TG and cholesterol contents in lipid extracts were determined as described by Jeon and others 24 . In brief, 5 mg extracted lipid was dissolved in 20 μL methanol:Triton X-100 1:1, v/v , and methanol was removed by N 2 gas. The lipid was then suspended in distilled water. Total-C and TG were measured enzymatically as described above.
Evaluation of fatty acid catabolism
To evaluate the influence on fatty acid metabolism, mice were orally intubated β-OO*P and the catabolic rate of 13 Clabeled palmitic acid 13 C-PA was determined as the ratio of 13 CO 2 / 12 CO 2 in expired gas by isotope ratio mass spectrometry IR-MS . This method was newly arranged to measure the activation of fatty acid β-oxidation in our previous study 25 and can provide evidence as to whether consumption of SO enhances disposing diet-derived fatty acids.
A sample emulsion containing β-OO*P was prepared as previously described 26 . In brief, β-OO*P was mixed with triolein, Triton X-100 and distilled water, and the mixture was emulsified using a Sonifier 250 ultrasonic homogenizer Branson Japan, Kanagawa, Japan . The emulsified TG intubation and expired gas collection were performed 2 days before dissection. The emulsion was orally intubated to the animals at a dose volume of 5 mL/kg body weight 0.4 mmol/kg 13 C-PA . To collect the expired gas, mice were individually placed in 450-mL plastic vessels for 5 min. The gas was collected with a 50-mL syringe and packed into 12-mL evacuated vials Exetainer, Labco, High Wycombe, UK . The expired gas was collected at 0, 15, 30, 45, 60, 75, 90, 105, 120, 180, and 240 min after intubation. The mice were fasted during sample collection. The actual ratio of 13 CO 2 / 12 CO 2 in the expired gas was analyzed using IR-MS ANCA-GSL, SerCon, Cheshire, UK and the catabolic rate of 13 C-PA was determined as described in our previous study 25 .
Fatty acid composition of diet and liver
Fatty acid compositions of the experimental diet and liver samples were analyzed using a gas chromatograph GC-2014, Shimadzu Corporation, Kyoto, Japan equipped with a frame ionization detector and Omegawax 320 fused silica capillary column Sigma-Aldrich Co. LLC., MO, USA . Fatty acid methyl esters were prepared with sodium hydroxide-methanol solution. The temperatures of the injection port and detector were 250 and 260 , respectively. The initial column temperature of 175 was held for 10 min and then increased to 225 at a rate of 1 /min. Fatty acids were identified by the retention time of a fatty acid methyl ester standard solution Supelco 37 Component FAME Mix, Sigma-Aldrich Co. LLC., MO, USA .
Statistical analysis
Each value represents the mean standard error of five mice. Significant differences between the 2 or 5 SO groups and the control group were assessed by the SteelDwass s multiple comparison test. The difference was considered significant when the P value was less than 0.05.
RESULTS
Effect on body weight and WAT weight
Body weight and WAT weight in C57BL/6N mice fed HF diet or HF diet containing 2 or 5 SO are summarized in Table 3 . Feeding of HF diet for 8 weeks significantly increased body weight, and there was no significant difference among the three groups. The weight of epididymal and perirenal WAT tended to be lower in the 2 and 5 SO groups than in the HF group, but not significantly different.
3.2 Blood biochemical parameters and lipid content in the liver The SO supplementation improved blood biochemical parameters and hepatic lipid accumulation in a dose-dependent manner Table 4 . Blood glucose level was significantly lower in mice fed the HF diet containing 5 SO than in those fed the same diet but without SO. Serum TG in the 5 SO group was about 50 lower than that in the HF group. Further, total-C levels were significantly decreased in the 2 and 5 SO groups, and the ratio of HDL-C to total-C was reversed by the SO diet.
The amounts of TG in the liver were lowered in the SO diet groups in a dose-dependent manner. Both 2 and 5 SO diets significantly lowered cholesterol levels in the liver, by about 35 and 40 , respectively.
Catabolic rate of 13 C-PA
To compare metabolic activity among the experimental groups, the catabolic rate of 13 C-PA contained in β-OO*P was measured using IR-MS as the ratio of 13 CO 2 / 12 CO 2 in expired gas Fig. 1 . The value in mice fed the HF diet significantly increased from 15 to 30 min and peaked at 60 min after fatty acid intubation. In the 5 SO group, the value increased more rapidly between 15 and 30 min and typically decreased substantially after 60 min compared to that seen in the HF group. Although a significant difference was not observed among the test groups at each measurement time point, the 5 SO group reached its maximum value at 45 min, while other groups reached their maximum after 60 min, indicating that lipid metabolic activity in the SO group was greater than that in the HF group.
Hepatic fatty acid composition
Dietary SO caused a significant increase in n-3 PUFA levels, especially EPA and DHA in the liver Table 5 . In comparison to the HF group, DHA levels were 2.2 and 2.7 times higher in the 2 and 5 SO groups, respectively. Moreover, the concentration of EPA was about 10 and 20 times higher in the 2 and 5 SO groups, respectively, than in the HF group.
In addition, an increase in stearic acid 18:0 and a decrease in oleic acid 18:1n-9 were observed in mice fed the 5 SO diet, suggesting that dietary SO could influence stearoyl-coenzyme A desaturase SCD activity in the liver. In order to determine the influence on lipid synthesis in the liver, the fatty acid desaturation index, the ratio of product palmitoleic acid 16:1n-7 and 18:1n-9 to precursor palmitic acid 16:0 and 18:0 , was analyzed. There were significant decreases in the ratios of 16:1n-7/16:0 and 18:1n-9/18:0 in the 5 SO group compared to those in the HF group.
DISCUSSION
The goal of the present study is to investigate the effects of dietary SO on metabolic disorders in C57BL/6N mice fed with an HF diet. The C57BL/6N strain is known to become severely obese and acquire hyperlipidemia based on insulin resistance when fed with HF diet. Rendina-Ruedy and others 27 showed that C57BL/6N mice treated with HF diet 45 kcal from fat had substantially increased body weight compared to mice fed a normal diet based on AIN-93M, and significant difference appeared after three weeks. In comparison to average data for C57BL/6N mice provided by Charles River Laboratories International, Inc. http:// www.criver.com/files/pdfs/rms/c57bl6/rm_rm_d_c57bl6n_ mouse.aspx , consistently, the HF diet used in this study 46 kcal from fat certainly increased body weight and TG levels in serum and the liver, indicating that an 8-week feeding with the HF diet successfully induced dysregulation of lipid metabolism in C57BL/6N mice. Under this condition, we assessed the influence of dietary SO on fatty acid catabolism and lipid synthesis, and found that SO supplementation was associated with amelioration of hepatic lipid storage and serum TG and cholesterol, despite body weight and fat mass being unchanged. Our findings showed Fig. 1 The effect on the activity of fatty acid metabolism.
The evaluation of the fatty acid metabolism was carried out at 2 days before dissection. Mice were orally intubated β-OO*P at the dose of 0.4 mol/kg body weight. that mice fed the SO diet were metabolically healthier than those fed the same diet but without SO. The first to be considered is the contribution of the high level of n-3 PUFA in SO to the lipid-lowering effect observed. It should be noted that SO is rich in n-3 PUFA bound not only to TG but also to phospholipid n-3 PL . Recent works on obese rodents, mainly fed with krill oil, have shown advanced effects of n-3 PL on hepatic steatosis in comparison to n-3 PUFA bound to TG 28, 29 . Additionally, Rossmeisl and others demonstrated a marked reduction in hepatic steatosis with herring-derived n-3 PL 30 . Studies on animals 31, 32 and humans 33, 34 have suggested that the stronger effect of n-3 PL is associated with their better bioavailability of EPA and DHA. These results indicate that the feature of lipid class in SO assist the beneficial effect of SO on lipid metabolism observed in the present study. It has been shown that n-3 PUFA alleviates hepatic lipid accumulation through an increase in the activation of peroxisome proliferator-activated receptor-alpha PPARα and a reduction in hepatic lipogenesis by downregulation of sterol regulatory element binding protein SREBP 15, 35, 36 .
The increased catabolic rate of intubated 13 C-PA into 13 CO 2 Fig. 1 observed in this study clearly demonstrates that SO enhances the disposal of excess fatty acid. In a study in which mice were treated with an HF diet containing EPA and DHA at a total dose of 8 g/kg, there was an upregulation of PPARα-regulated genes in the liver, associated with reductions in both body weight and hepatic lipid storage 37 .
The fat content in the HF diet used in that study 15 wt ; equivalent to 32 by energy , was much lower than that used in the present study 25 wt , which may explain why the SO diet failed to decrease body weight and WAT mass even though the concentration of EPA plus DHA was comparable in the experimental diet 4.7 g/kg and 14.3 g/kg in the 2 and 5 SO diets, respectively . However, there was an enhancement of fatty acid catabolism, suggesting that the decreased hepatic fat storage and serum TG in the SO diet groups was partly due to an increase in β-oxidation through PPARα activation in the liver.
Several studies have reported that EPA strongly suppresses hepatic lipogenesis through suppressing the expression of SREBP 35, 36 , a key regulator of lipogenic gene transcription. Consistently, dietary SO lowered the content of TG in the serum and liver with an increase in EPA levels compared to the HF diet without SO. In addition, analysis of hepatic FA composition revealed decreases in the ratios of monounsaturated fatty acid MUFA to saturated fatty acid SFA , C16:1/C16:0 and C18:1/C18:0, in the mice fed SO, suggesting downregulation of SCD-1 activity in the liver. SCD-1, a downstream target of SREBP, is known to catalyze delta-9 desaturation of SFA such as C16:0 and C18:0 mainly in the liver and adipose tissue, and recent studies have shown a relationship between the high expression of SCD-1 and development of obesity and metabolic syndrome 38, 39 . An earlier study demonstrated that suppression of SCD-1 by EPA prevents hepatic steatosis in diet-induced obese mice 40 . Based on these results, the decrease in hepatic TG in mice fed the SO diets is likely to be a result of modulation of SREBP expression and its target genes including SCD-1 in the liver. SREBP also regulates the transcription of cholesterol synthesis enzymes, such as 3-hydroxy-3-methylglutarylCoA reductase HMG-CoA reductase , the rate-limiting enzyme. N-3 PUFA is known to improve cholesterol and lipoprotein metabolism 41, 42 , and its hypocholesterolemic effect is mainly due to suppression of HMG-CoA reductase at the transcriptional level 43, 44 . Le Jossic-Corcos and others showed that EPA and DHA exhibit inhibitory effects on cholesterol production through reduction of these genes in human hepatoma HepG2 cells, and suggested that such negative effects occur as a result of downregulation of SREBP gene expression. This suggests the possibility that increased EPA and DHA levels in the liver may cause the lowering of hepatic and serum cholesterol observed in SO mice.
In addition to EPA, SO contains a high level of eicosenoic acid, a long chain-monounsaturated fatty acid LC-MUFA with a 20-carbon aliphatic tail. Recently, Yang and others examined the effect of LC-MUFA-concentrated oil on metabolic disorders and found that consumption of LC-MUFA at a dose of 4-7 w/w improves several metabolic parameters in obese and type 2 diabetic mice 45, 46 . Based on these results, there is a possibility that eicosenoic acid plays a role in the positive effect of SO on lipid metabolism. Since the content of eicosenoic acid in the SO diet, approximately 1.1 in the 5 SO diet, was lower than that in these studies, further studies are needed to clarify the contribution of eicosenoic acid to the effect of the SO diet. Insulin action regulates TG secretion as VLDL particles and chylomicron clearance, both of which are associated with hepatic lipid storage 47, 48 . Therefore, the significant decrease in non-fasting blood glucose levels observed in the present study indicates that insulin sensitivity is maintained by dietary SO, which could be another factor in the prevention of lipid metabolism disorders in the liver. Numerous studies have demonstrated the ability of n-3 PUFA to preserve insulin sensitivity in HF diet-induced obese mice 49, 50 . Furthermore, it is possible that astaxanthin, a dominant carotenoid in SO 18 , could be responsible for the glucose-lowering effect. Astaxanthin has been shown to prevent diet-induced hyperglycemia and steatohepatitis along with improving insulin signaling 51 . The antioxidant activity of astaxanthin is considered to contribute to a decrease in ROS generation, which causes lipid peroxidation and the subsequent development of insulin resistance in obese mice 51 . Interestingly, Saw and others showed that astaxanthin and EPA/DHA synergistically reduce oxidative stress through the induction of antioxidant enzymes in a HepG2 cell line system 52 . These results suggest that the improved glucose and lipid metabolism observed in SO mice may have been partly due to the individual and additive/synergistic effects of n-3 PUFA and astaxanthin.
CONCLUSION
Our results demonstrate that dietary SO prevents hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. These positive effects were partly due to the enhancement of fatty acid β-oxidation and suppression of TG and cholesterol synthesis in the liver. The complex lipid components, including n-3 PUFA both in TG and PL form, and carotenoids in SO could be responsible, either individually or in combination, for the multiple effects observed that may improve metabolic disorders.
